CLASS II Device recall · Reported 15 Aug 2012 · FDA Enforcement Report

i-Stat Ck-mp cartridges Abbott Point of Care Inc. recalled

Abbott Point Of Care is recalling i-Stat Ck-mp cartridges Abbott Point of Care Inc. The i-Stat Ckmb test is an in vitro, distributed nationwide in the US. The recall was initiated on 1 Feb 2012 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesList number 06F25-01, 06F25-02, 03P92-25, All lots
Quantity recalled368,149 cartridges US; 32,725 OUS

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2171-2012
FDA event ID
62533
Recalling firm
Abbott Point Of Care, Princeton, NJ
Classification
Class II
Status
Terminated
Recall initiated
1 Feb 2012
FDA classified
9 Aug 2012
Reported
15 Aug 2012
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

1 Feb 2012Recall initiated by company
9 Aug 2012Classified by FDA+190 days
15 Aug 2012Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The frequency of suppressed results for i-Stat cTnl, BNP and CK-MP cartridges is affected by atmospheric pressure.

Product as listed by the FDA

i-Stat CK-MP cartridges Abbott Point of Care Inc. The i-Stat CKMB test is an in vitro diagnostic test for the quantitative measurement of creatinine kinase MB mass in whole blood or plasma samples. CK-MB measurements can be used as an aid in the diagnosis and treatment of myocardial infarction (MI).

Where it was distributed

Worldwide Distribution - USA including AZ and CO and internationally to Argentina, Australia, Austria, Belgium, Bolivia, Brazil, Chile, China, Colombia, Costa Rica, Dominican Republic, El Salvador, Finland, France, Georgia, Germany, Greece, Honduras, Hong Kong, India, Ireland, Italy, Korea, Kuwait, Mauritius, Mexico, Netherland (Antilles), Nigeria, Norway, Oman, Paraguay, Peru, Poland, Portugal, Qatar, Russia, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, R.O.C., Thailand, UAE, United Kingdom, and Yemen.

Nationwide ArizonaColoradoGeorgia

Questions about this recall

Is i-Stat Ck-mp cartridges Abbott Point of Care Inc. The i-Stat Ckmb test is an in vitro recalled?

Yes. Abbott Point Of Care recalled i-Stat Ck-mp cartridges Abbott Point of Care Inc. The i-Stat Ckmb test is an in vitro on 1 Feb 2012. The recall is Class II and its status is Terminated. Recall number Z-2171-2012.

Why was it recalled?

The frequency of suppressed results for i-Stat cTnl, BNP and CK-MP cartridges is affected by atmospheric pressure.

Which lots are affected?

List number 06F25-01, 06F25-02, 03P92-25, All lots

Where was it sold?

Worldwide Distribution - USA including AZ and CO and internationally to Argentina, Australia, Austria, Belgium, Bolivia, Brazil, Chile, China, Colombia, Costa Rica, Dominican Republic, El Salvador, Finland, France, Georgia, Germany, Greece, Honduras, Hong Kong, India, Ireland, Italy, Korea, Kuwait, Mauritius, Mexico, Netherland (Antilles), Nigeria, Norway, Oman, Paraguay, Peru, Poland, Portugal, Qatar, Russia, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, R.O.C., Thailand, UAE, United Kingdom, and Yemen.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Abbott Point Of Care

All 31

Other Test Kits & Diagnostics recalls

All 2,656